|
2025
|
Invention
|
Extended-release microsphere drug conjugates. Disclosed herein are microsphere (MS)-drug conjugat... |
|
|
Invention
|
Extended-release conjugates of lipidated peptides, and uses thereof. Provided herein are conjugat... |
|
|
Invention
|
Conjugation linkers.
Provided are β-eliminative linkers suitable for the conjugation of small mo... |
|
|
Invention
|
Pegylated il- 15 receptor alpha cytokines. Provided herein are IL-15 cytokine therapeutics showin... |
|
|
Invention
|
Protocol for minimizing toxicity of combination dosages and imaging agent for verification.
Adva... |
|
|
Invention
|
Locoregional therapies using slow-release conjugates. Provided herein are locoregional therapies ... |
|
2023
|
Invention
|
Methods of treating cancer with long-acting topoisomerase i inhibitor.
The disclosure provides m... |
|
|
Invention
|
Treating cancer with long-acting topoisomerase i inhibitor.
The disclosure provides method of tr... |
|
|
Invention
|
Methods of treating cancer with long-acting topoisomerase i inhibitor. The disclosure provides me... |
|
|
Invention
|
Treating cancer with long-acting topoisomerase i inhibitor. The disclosure provides method of tre... |
|
|
Invention
|
Synergistic cancer treatment.
Conjugates of topoisomerase I inhibitors linked to a macromolecule... |
|
2022
|
Invention
|
Hydrogels with biodegradable crosslinking. Hydrogels that degrade under appropriate conditions of... |
|
|
Invention
|
High-throughput microemulsification membrane.
The present disclosure is related to high-throughp... |
|
|
Invention
|
High-throughput microemulsification membrane. The present disclosure is related to high-throughpu... |
|
2021
|
Invention
|
Extended release hydrogel conjugates of c-natriuretic peptides.
Provided herein are extended rel... |
|
|
Invention
|
Extended release hydrogel conjugates of c-natriuretic peptides. Provided herein are extended rele... |
|
2020
|
Invention
|
Conjugated inhibitors of dna damage response. Provided herein are releasable conjugates of inhibi... |
|
|
Invention
|
Steam sterilization of hydrogels crosslinked by beta-eliminative linkers.
Methods for the steam ... |
|
|
Invention
|
Steam sterilization of hydrogels crosslinked by beta-eliminative linkers. Methods for the steam s... |
|
|
Invention
|
Slow-release cytokine conjugates. This disclosure generally relates to releasable cytokine conjug... |
|
|
Invention
|
Conjugation linkers. Provided are β-eliminative linkers suitable for the conjugation of small mol... |
|
|
Invention
|
Improved conjugation linkers. Provided are β-eliminative linkers suitable for the conjugation of ... |
|
|
Invention
|
Improved conjugation linkers. Provided are ß-eliminative linkers suitable for the conjugation of ... |
|
2019
|
Invention
|
Aseptic method and apparatus to prepare sterile formulations of drug-linked hydrogel microspheres... |
|
|
Invention
|
Synergistic cancer treatment. Conjugates of topoisomerase I inhibitors linked to a macromolecule ... |
|
|
Invention
|
Protocol for minimizing toxicity of combination dosages and imaging agent for verification. Advan... |
|
|
Invention
|
Synergistic cancer treatment. in situin situ in combination with one or more of an assessed defec... |
|
2018
|
Invention
|
Conjugates of somatostatin analogues. Conjugates of carriers and hydrogels for controlling the bi... |
|
|
Invention
|
Slow-release conjugates of sn-38. Conjugates of SN-38 that provide optimal drug release rates and... |
|
2017
|
Invention
|
Extended release conjugates of exenatide analogs.
Extended-release conjugates of stabilized GLP-... |
|
|
Invention
|
Extended release conjugates of exenatide analogs. Extended-release conjugates of stabilized GLP-1... |
|
2015
|
Invention
|
Reagents for thiol conjugation and conjugates formed therefrom. Reagents for preparing stabilized... |
|
2014
|
Invention
|
Conjugates of somatostatin and its analogs. Conjugates of carriers and hydrogels for controlling ... |
|
|
Invention
|
Sealants having controlled degration.
The invention provides sealants wherein biodegradable hydr... |
